Nuclear Medicine Market
Nuclear Medicine Market Research Report Information By Product Type ( Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals [ Tc-99m, TI-201, Ga-67, I-123, and Others], Pet Radiopharmaceuticals [Tc-99m, TI-201, Ga-67, I-123, and Others]), Therapeutic Nuclear Medicine (Alpha Emitters[ Ra-223], Beta Emitters[I-131, Y-90, Sm-153, Lu-177, Re-186, and Others]), Brachytherapy Isoptopes [Ir-192, I-125, Pd-103, Cs-131, and Others]), By Application (Diagnostic Applications SPECT Applications[Cardiology, Neurology, Lymphoma, Thyroid, and Others], PECT Applications[Oncology, Cardiology, Neurology, and Others], Therapeutic Applications (Thyriod, Bone Metastasis, Endrocrine Tumors, Lymphoma, and Others), By End User(Hospitals And Diagnostic Centers, Research Institutes, and Others)and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032.
Global Nuclear Medicine Market Overview
Nuclear Medicine Market Size was valued at USD 6.24 billion in 2021 and is projected to grow from USD 7.06 billion in 2022 to USD 24.03 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13...